{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:13:22Z","timestamp":1788311602214,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12673-4","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:16:39Z","timestamp":1769739399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of the diagnostic value of targeted next-generation sequencing, metagenomic next-generation sequencing, and Xpert MTB\/RIF in adult pulmonary tuberculosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Qiaoqian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionghui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"12673_CR1","unstructured":"Global tuberculosis report 2024. Geneva: World Health Organization. 2024. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024."},{"issue":"8","key":"12673_CR2","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/s1473-3099(19)30307-x","volume":"19","author":"GM Knight","year":"2019","unstructured":"Knight GM, F MC, Dodd P J, et al. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. The Lancet Infect Dis. 2019;19(8):903\u201312. https:\/\/doi.org\/10.1016\/s1473-3099(19)30307-x.","journal-title":"The Lancet Infect Dis"},{"issue":"10202","key":"12673_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(19)31882-3","volume":"394","author":"C Lange","year":"2019","unstructured":"Lange C, Dheda K, Chesov D, et al. Management of drug-resistant tuberculosis. The Lancet. 2019;394(10202):953\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(19)31882-3.","journal-title":"The Lancet"},{"key":"12673_CR4","unstructured":"World Health Organization. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: xpert MTB\/RIF system[M]\/\/Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance. Xpert MTB\/RIF System. 2011;35\u201335. https:\/\/www.who.int\/publications\/i\/item\/9789241501545."},{"issue":"9915","key":"12673_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/s0140-6736(13)62073-5","volume":"383","author":"G Theron","year":"2014","unstructured":"Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB\/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. The Lancet. 2014;383(9915):424\u201335. https:\/\/doi.org\/10.1016\/s0140-6736(13)62073-5.","journal-title":"The Lancet"},{"key":"12673_CR6","doi-asserted-by":"publisher","unstructured":"Yadav R, Vaidya P, Mathew L, J, et al. Utility of Xpert MTB\/RIF assay for diagnosis of pediatric tuberculosis under programmatic conditions in India. J Epidemiol Glob Health. 2020;10(2):153\u201356. https:\/\/doi.org\/10.2991\/jegh.k.191215.002.","DOI":"10.2991\/jegh.k.191215.002"},{"issue":"12","key":"12673_CR7","doi-asserted-by":"publisher","first-page":"e0277145","DOI":"10.1371\/journal.pone.0277145","volume":"17","author":"GT Akalu","year":"2022","unstructured":"Akalu GT, Tessema B, Petros B. High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB\/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia. PLoS One. 2022;17(12):e0277145. https:\/\/doi.org\/10.1371\/journal.pone.0277145.","journal-title":"PLoS One"},{"issue":"3","key":"12673_CR8","doi-asserted-by":"publisher","first-page":"dlab101","DOI":"10.1093\/jacamr\/dlab101","volume":"3","author":"MM Fitzgibbon","year":"2021","unstructured":"Fitzgibbon MM, Roycroft E, Sheehan G, et al. False detection of rifampicin resistance using Xpert\u00ae MTB\/RIF Ultra assay due to an A451V mutation in Mycobacterium tuberculosis. JAC-Antimicrob Resist. 2021;3(3):dlab101. https:\/\/doi.org\/10.1093\/jacamr\/dlab101.","journal-title":"JAC-Antimicrob Resist"},{"key":"12673_CR9","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module, 3: diagnosis-rapid diagnostics for tuberculosis detection[M]. World Health Organ. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240089488."},{"key":"12673_CR10","unstructured":"World Health Organization. Use of targeted next-generation sequencing to detect drug-resistant tuberculosis: rapid communication, July 2023[M]. World Health Organization. 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240076372."},{"key":"12673_CR11","doi-asserted-by":"publisher","first-page":"984753","DOI":"10.3389\/fcimb.2022.984753","volume":"12","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang H, Li Y, et al. Clinical application of metagenomic next-generation sequencing in tuberculosis diagnosis. Front Cellular Infect Microbiol. 2023;12:984753. https:\/\/doi.org\/10.3389\/fcimb.2022.984753.","journal-title":"Front Cellular Infect Microbiol"},{"issue":"11","key":"12673_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3760\/cma.J.c.n112147-20200508-00570","volume":"43","author":"Tuberculosis Branch of the Chinese Medical Association","year":"2020","unstructured":"Tuberculosis Branch of the Chinese Medical Association. Diagnosis and treatment guidelines for Nontuberculous mycobacterial diseases (2020 Edition). Chin J Tuberc Respir Dis. 2020;43(11):918\u201346. https:\/\/doi.org\/10.3760\/cma.J.c.n112147-20200508-00570.","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"4","key":"12673_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3760\/cma.j.cn114452-20240911-00506","volume":"48","author":"World Chinese Medical Fungi Professional Committee. Expert Consensus on Diagnostic Pathways for Invasive Pulmonary Mycosis","year":"2025","unstructured":"World Chinese Medical Fungi Professional Committee. Expert Consensus on Diagnostic Pathways for Invasive Pulmonary Mycosis (2024 Edition). Chin J Lab Med. 2025;48(4):459\u201368. https:\/\/doi.org\/10.3760\/cma.j.cn114452-20240911-00506.","journal-title":"Chin J Lab Med"},{"issue":"4","key":"12673_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3760\/cma.j.issn.1000-6680.2018.04.001","volume":"36","author":"Infectious diseases Branch of the Chinese Medical Association","year":"2018","unstructured":"Infectious diseases Branch of the Chinese Medical Association. Expert Consensus on diagnosis and treatment of cryptococcal meningitis. Chin J Infect Dis. 2018;36(4):193\u201399. https:\/\/doi.org\/10.3760\/cma.j.issn.1000-6680.2018.04.001.","journal-title":"Chin J Infect Dis"},{"key":"12673_CR15","doi-asserted-by":"publisher","unstructured":"Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American thoracic society and the centers for disease control and prevention was adopted by the ATS board of directors, July 1999. This statement was endorsed by the council of the infectious disease society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1376\u201395. https:\/\/doi.org\/10.1164\/ajrccm.161.4.16141.","DOI":"10.1164\/ajrccm.161.4.16141"},{"issue":"1","key":"12673_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41512-022-00125-x","volume":"6","author":"EL MacLean","year":"2022","unstructured":"MacLean EL, Kohli M, K\u00f6ppel L, et al. Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis tests. Diagn Progn Res. 2022, Jun, 16;6(1):11. https:\/\/doi.org\/10.1186\/s41512-022-00125-x.","journal-title":"Diagn Progn Res"},{"issue":"11","key":"12673_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/thoraxjnl-2018-211715","volume":"73","author":"JE Stout","year":"2018","unstructured":"Stout JE, Wu Y, Ho CS, et al. Tuberculosis epidemiologic studies consortium. Evaluating latent tuberculosis infection diagnostics using latent class analysis. Thorax. 2018, Nov;73(11):1062\u201370. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211715. Epub 2018 Jul 7.","journal-title":"Thorax"},{"key":"12673_CR18","doi-asserted-by":"publisher","unstructured":"Steingart KR, Sohn H, Schiller I, et al. Xpert \u00ae MTBC\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults[J]. Cochrane Database Systematic Rev. 2013;1. https:\/\/doi.org\/10.1002\/14651858.cd009593.pub2.","DOI":"10.1002\/14651858.cd009593.pub2"},{"key":"12673_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fcimb.2019.00351","volume":"9","author":"X Zhou","year":"2019","unstructured":"Zhou X, Wu H, Ruan Q, et al. Clinical evaluation of diagnosis efficacy of active mycobacterium tuberculosis complex infection via metagenomic next-generation sequencing of direct clinical samples. Front Cellular Infect Microbiol. 2019;9:351. https:\/\/doi.org\/10.3389\/fcimb.2019.00351.","journal-title":"Front Cellular Infect Microbiol"},{"issue":"5","key":"12673_CR20","doi-asserted-by":"publisher","first-page":"e04098","DOI":"10.1128\/spectrum.04098-23","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dai X, Hu P, et al. Comparison of targeted next-generation sequencing and the Xpert MTB\/RIF MTBC\/RIF assay for detection of Mycobacterium tuberculosis in clinical isolates and sputum specimens. Microbiol Spectr. 2024;12(5):e04098\u201323. https:\/\/doi.org\/10.1128\/spectrum.04098-23.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"12673_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12916-025-03996-1","volume":"23","author":"Y Chen","year":"2025","unstructured":"Chen Y, Fan L, Ren Z, et al. Sensitive diagnosis of paucibacillary tuberculosis with targeted next-generation sequencing: a molecular diagnostic study. BMC Med. 2025, Mar, 26;23(1):178. https:\/\/doi.org\/10.1186\/s12916-025-03996-1.","journal-title":"BMC Med"},{"issue":"4","key":"12673_CR22","doi-asserted-by":"publisher","first-page":"e0176186","DOI":"10.1371\/journal.pone.0176186","volume":"12","author":"G Lombardi","year":"2017","unstructured":"Lombardi G, Di Gregori V, Girometti N, et al. Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB\/RIF MTBC\/RIF. PLoS ONE. 2017;12(4):e0176186. https:\/\/doi.org\/10.1371\/journal.pone.0176186.","journal-title":"PLoS One"},{"key":"12673_CR23","doi-asserted-by":"publisher","unstructured":"Zheng H, Yang H, Wang Y, et al. Diagnostic value of tNGS vs Xpert MTB\/RIF in childhood TB. Heliyon. 2024;10(1). https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23217.","DOI":"10.1016\/j.heliyon.2023.e23217"},{"key":"12673_CR24","doi-asserted-by":"publisher","unstructured":"Tao Y, Zhou Z, Duan Y, et al. Diagnostic value of targeted next-generation sequencing in pulmonary mycobacterial infections. Curr Med Sci. 2024;1\u20137. https:\/\/doi.org\/10.1007\/s11596-024-2937-4.","DOI":"10.1007\/s11596-024-2937-4"},{"key":"12673_CR25","doi-asserted-by":"publisher","unstructured":"Chang CY, Hong JY, Yuan MK, et al. Risk factors in patients with AFB smear-positive sputum who receive inappropriate antituberculous treatment. Drug Des, Devel Ther. 2013;53\u201358. https:\/\/doi.org\/10.2147\/dddt.s39247.","DOI":"10.2147\/dddt.s39247"},{"issue":"3","key":"12673_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.chest.2021.10.003","volume":"161","author":"K Kumar","year":"2022","unstructured":"Kumar K, Loebinger M R. Nontuberculous mycobacterial pulmonary disease: clinical epidemiologic features, risk factors, and diagnosis: the nontuberculous mycobacterial series. Chest. 2022;161(3):637\u201346. https:\/\/doi.org\/10.1016\/j.chest.2021.10.003.","journal-title":"Chest"},{"key":"12673_CR27","doi-asserted-by":"publisher","unstructured":"Uddin M K M, Cabibbe A M, Nasrin R, et al. Targeted next-generation sequencing of Mycobacterium tuberculosis from patient samples: lessons learned from high drug-resistant burden clinical settings in Bangladesh. Emerging Microbes Infections. 2024;13(1):2392656. https:\/\/doi.org\/10.1080\/22221751.2024.2392656.","DOI":"10.1080\/22221751.2024.2392656"},{"key":"12673_CR28","doi-asserted-by":"publisher","unstructured":"Murphy SG, Smith C, Lapierre P, et al. Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing. Front Public Health. 2023;11:1206056. https:\/\/doi.org\/10.3389\/fpubh.2023.1206056.","DOI":"10.3389\/fpubh.2023.1206056"},{"key":"12673_CR29","doi-asserted-by":"publisher","unstructured":"Xu F, Wang Q, Zhang N, et al. Simultaneous diagnosis of tuberculous pleurisy and malignant pleural effusion using metagenomic next-generation sequencing (mNGS). J Transl Med. 2023;21(1):680. https:\/\/doi.org\/10.1186\/s12967-023-04492-x.","DOI":"10.1186\/s12967-023-04492-x"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12673-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12673-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12673-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:26:37Z","timestamp":1777328797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12673-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12673"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12673-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Fuzhou Pulmonary Hospital (reference no. 2023\u2013004-02) following the World Medical Association\u2019 s Declaration of Helsinki. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"840"}}